Document is current

Article History

Received: 27 October 2024

Accepted: 19 March 2025

First Online: 8 April 2025

Declarations

:

: AM has received research support from the Swiss National Science Foundation (SNSF). Also, he has received personal compensation from Strategy& (part of PwC) and High-Tech Grunderfonds. JZ reports research support from the Elizabeth Kremer Foundation, Novartis, NIH, I-Mab Biopharma and the Race to Erase MS Foundation. BCH reports research support from Bristol Myers Squibb, Novartis and Genzyme. SS reports no disclosures. HL reports no disclosures. MQ reports no disclosures. RC reports no disclosures. HLW - Dr. Weiner has received research support from NIH, NMSS, EMD Serono, Novartis, Sanofi Genzyme, Teva Neurosciences, and Verily Life Sciences, and personal and consulting fees from Genentech, Tiziana Life Sciences, Tilos Therapeutics, IM Therapeutics, vTv Therapeutics and MedDay Pharmaceuticals. RB - Dr. Bakshi has received speaking honoraria from EMD Serono and Sanofi and research support from Bristol Myers Squibb, EMD Serono, and Novartis. TC - Dr. Chitnis has received compensation for speaking engagements from Prime Education, LLC. Dr. Chitnis has received research support from the National Institutes of Health, National MS Society, US Department of Defense, Sumaira Foundation, Brainstorm Cell Therapeutics, Bristol Myers Squibb, Genentech, EMD Serono, I-Mab Biopharma, Mallinckrodt ARD, Massachusetts Life Sciences Center, Novartis Pharmaceuticals, Octave Bioscience, Sanofi Genzyme, Tiziana Life Sciences, and Wesley Clover International.